299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02010411 (ClinicalTrials.gov)	June 2004	9/12/2013	Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis	Effects of Prolastin Aerosol Therapy on Bacterial Density in the Airways of Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Prolastin (drug)	Université de Sherbrooke	NULL	Terminated	14 Years	N/A	Both	17	Phase 2	Canada
2	NCT00486837 (ClinicalTrials.gov)	December 2003	13/6/2007	Deposition of Inhaled Prolastin in Cystic Fibrosis Patients	Multicenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF)	Cystic Fibrosis	Drug: Alpha1-Proteinase Inhibitor (Human)	Grifols Therapeutics Inc.	NULL	Completed	8 Years	N/A	All	72	Phase 2	NULL